Presentation TCT 2016 Direct Annuloplasty I: Cardioband TF Trial Results and Future Directions Presenter: Ted Feldman, Scott Lim, Francesco Maisano October 31, 2016
Presentation TCT 2016 Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Michael Argenziano, Alec S. Vahanian, Blase A. Carabello October 31, 2016
Presentation TCT 2016 Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Michael Argenziano, Alec S. Vahanian, Daniel Burkhoff October 31, 2016
Presentation TCT 2016 Rationale for and Design of GALILEO Presenter: Michael Argenziano, Alec S. Vahanian, Paul Sorajja October 31, 2016
Presentation TCT 2016 Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara October 31, 2016
Presentation TCT 2016 Rationale for and Design of ABSORB IV (Five-Year Results): What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Jorge Gaspar, Davide Capodanno October 30, 2016
Presentation TCT 2016 Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Jorge Gaspar, C. Michael Gibson October 30, 2016
Presentation TCT 2016 Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Jorge Gaspar, Bernard J. Gersh October 30, 2016
Presentation TCT 2016 Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Jorge Gaspar, Anthony H. Gershlick October 30, 2016
Presentation TCT 2016 Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial Presenter: A. Pieter Kappetein, Allan Schwartz, Martin B. Leon October 30, 2016
Presentation TCT 2016 Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial Presenter: Patrick T. O'Gara, Alec S. Vahanian, Jeffrey J. Popma October 30, 2016
Presentation TCT 2016 Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial Presenter: Patrick T. O'Gara, Alec S. Vahanian, Michael J. Mack October 30, 2016
Presentation TCT 2016 Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Bryan Williams October 30, 2016
Presentation TCT 2016 Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials Presenter: Patrick T. O'Gara, Alec S. Vahanian, Susheel K. Kodali October 30, 2016
Presentation TCT 2015 Data Gaps and Future Trial Pathways: Possible Study Designs for New Devices, Anticoagulation Ineligible Patients, and Comparative NOAC Data Presenter: Nicole Ibrahim, Saibal Kar, Zoltan G. Turi October 14, 2015
Presentation TCT 2015 HOT TOPIC 5: Debate Patient-Centered/-Reported Outcomes in Device Studies: How Will This Shape the Future of Clinical Studies? Con Level of Evidence Is Weak! Presenter: Ajay J. Kirtane, Roxana Mehran, Daniel I. Simon October 12, 2015
Presentation TCT 2015 HOT TOPIC 5: Debate Patient-Centered/-Reported Outcomes in Device Studies: How Will This Shape the Future of Clinical Studies? Pro The Patient Matters Most! Presenter: Ajay J. Kirtane, Roxana Mehran, Suzanne V. Arnold October 12, 2015
Presentation TCT 2015 Coherex WaveCrest and the WAVECREST 2 Randomized Trial Presenter: Brij Maini, Horst Sievert, Brian K. Whisenant October 12, 2015
Presentation TCT 2015 HOT TOPIC 4: Debate Is Big Data the Future of Comparative-Effectiveness Analysis? Maybe, but Be Afraid, Be Very Afraid! Presenter: Bernard J. Gersh, William S. Weintraub, Robert A. Harrington October 12, 2015
Presentation TCT 2015 HOT TOPIC 4: Debate Is Big Data the Future of Comparative-Effectiveness Analysis? Yes, the Writing Is in the Cloud! Presenter: Bernard J. Gersh, William S. Weintraub, Matthew T. Roe October 12, 2015